PATENT CLAIM ANALYSIS

Application Number: 15745105
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["424", "489000"]

Abstract:
Disclosed is the use of copper cysteamine nanoparticles for use in photodynamic cancer therapy. The disclosed methods of treatment utilize microwave radiation as a means for activating the copper cysteamine photosensitizer.

Claim (Index 23):
The photodynamic therapy according to  claim 20 , wherein the composition comprises from about 5 \u03bcg/mL to about 20 \u03bcg/mL of the copper cysteamine nanoparticles.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 1.26923
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15421292', '14907595', '14695951', '14457650', '15785782']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6822150708773966
- 35 USC 102 Novelty (BERT): 0.5055472532403114
- Combined Prediction Score: 0.6645482891136881
- Mean Citation Score: 192.635452
- Max Citation Score: 210.45834
- Similarity Product: 139.06699071022868

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test